Zhengye Biotechnology Holding Limited
Income Statement
| Line Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $16.6M | $25.5M |
| Cost of Revenue | $13.2M | $13.0M |
| Gross Profit | $3.4M | $12.5M |
| Gross Margin | 20.5% | 49.0% |
| Operating Expenses | ||
| Research & Development | $2.6M | $1.8M |
| SG&A Expense | $4.4M | $3.1M |
| Operating Income | $-10.1M | $2.3M |
| Operating Margin | -60.6% | 8.8% |
| Interest Expense | $486.0K | $554.0K |
| Pretax Income | $-10.3M | $2.0M |
| Income Tax Expense | $1.6M | $127.0K |
| Net Income | $-10.0M | $1.6M |
| Net Margin | -60.0% | 6.1% |
| EPS (Basic) | — | $0.03 |
| EPS (Diluted) | — | $0.03 |
| Shares Outstanding (Basic) | 47.3M | 45.7M |
| Shares Outstanding (Diluted) | 47.3M | 45.7M |
| Dividends Per Share | — | — |